CYP2D6 genotype and endoxifen plasma concentration do not predict hot flash severity during tamoxifen therapy
ConclusionsHot flash severity during tamoxifen therapy can not be accounted for byCYP2D6 genotype or observed plasma concentration of tamoxifen, 4-hydroxytamoxifen, or endoxifen.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Genetics | Men | Menopause | Study | Tamoxifen